A LinkedIn post from FluidAI Medical highlights a recent visit by Dr. Rishi Reddy, Director of the Lung Transplant Program at the University of Michigan and Head of the Center for Surgical Innovation. The post notes that Dr. Reddy is a longstanding partner who uses FluidAI’s solutions firsthand in clinical settings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests FluidAI is maintaining close collaboration with leading academic clinicians to refine its products around real-world workflows. For investors, this ongoing engagement with a high-profile transplant and innovation leader may indicate sustained validation of the technology, potential for stronger clinical evidence, and enhanced prospects for broader hospital adoption over time.

